查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1429613

2024 年放射性藥物全球市場報告

Radiopharmaceuticals Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年放射性藥物市場規模將快速成長。預計到 2028 年將以 11.8% 的複合年成長率 (CAGR) 成長至 105.9 億美元。預測期間的預期成長可歸因於老年人口增加、癌症和心血管疾病盛行率上升、資本支出高以及新產品推出等因素。這段時期的顯著趨勢包括與其他公司合作提高收益和產品品質、投資擴大工廠產能以滿足不斷成長的需求，以及採用新技術、在製造中實施 3D 列印技術以降低成本以及投資於諸如作為：為了追求治療領域的領導地位，探索In Silico建模以尋求更合理和科學的方法，利用人工智慧來降低研發成本並加速藥物開發，並透過投資以心臟病為重點的技術來增加收益。此外，採用針對特定疾病的方法來準確、及時地診斷癌症是一個顯著的趨勢。

癌症和心血管疾病發生率的增加預計將成為放射性藥物市場的驅動力。放射性藥物越來越被認為是傳統藥物的安全有效的治療方法替代品。這些為放射科醫師在癌症和心血管疾病的治療中提供了明顯的優勢，這主要是由於標靶治療的好處。癌症是第二大死因，全世界大約六分之一的死亡是由癌症造成的。根據國際癌症研究機構 (IARC) 預測，到 2040 年，人口成長和老化將使全球負擔達到 2,750 萬活躍癌症病例和 1,630 萬癌症死亡人數。值得注意的是，大約 70% 的癌症死亡發生在低收入和中等收入國家。因此，癌症和心血管疾病盛行率的增加預計將增加對治療這些疾病的放射性藥物的需求。

由於對個人化醫療的需求不斷增加，放射性藥物市場預計將顯著成長。個人化醫療，也稱為精準醫療，是一種創新的醫療保健方法，可根據每位患者的獨特特徵量身定做醫療決策、治療、干預措施和藥物。將個人化醫療與放射性藥物結合可以提高影像處理和治療的準確性，使醫療保健提供者能夠提供更有針對性和更有效的護理。例如，2022年，食品藥物管理局藥物評估與研究中心（CDER）核准了37個新分子實體（NME），其中約34%即12個被個人化醫療聯盟歸類為個人化醫療（ PMC ）。完成了。因此，個人化醫療需求的不斷成長正在推動放射性藥物市場的成長。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球放射性藥物市場的驅動與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023年全球放射性藥物市場規模表現及成長率
  • 2023-2028、2033年全球放射性藥物市場規模及成長預測

第6章市場區隔

  • 全球放射性藥物市場，按類型細分、實際和預測，2018-2023、2023-2028、2033
  • 診斷
  • 治療
  • 其他
  • 全球放射性藥物市場，按應用、性能和預測細分，2018-2023、2023-2028、2033
  • 腫瘤學
  • 心臟病學
  • 消化內科
  • 神經內分泌學
  • 神經病學
  • 腎臟病學
  • 其他
  • 全球放射性藥物市場，按最終用戶細分，實際和預測，2018-2023、2023-2028、2033
  • 醫院
  • 門診手術中心
  • 診斷中心
  • 癌症研究
  • 其他

第 7 章 區域與國家分析

  • 全球放射性藥物市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球放射性藥物市場，依國家、績效及預測，2018-2023年、2023-2028、2033年

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 放射性藥物市場競爭形勢
  • 放射性藥物市場公司概況
    • Cardinal Health
    • Curium Pharma
    • Siemens Healthineers AG
    • Novartis AG
    • General Electric Company（GE）

第31章 其他大型創新公司

  • IBA Group
  • Bayer AG
  • Lantheus Medical Imaging Inc.
  • Bracco Imaging SpA
  • Eckert &Ziegler
  • Nihon Medi-Physics Co. Ltd.
  • Fujifilm Corporation
  • ANSTO
  • Yantai Dongcheng Pharmaceutical Group Co. Ltd.
  • Bracco Imaging SpA.
  • Canon Inc.
  • China Isotope &Radiation Corporation（CIRC）
  • Alliance Medical
  • Advanced Accelerator Applications
  • JSC Isotope

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與潛力分析

第36章附錄

簡介目錄
Product Code: r14584

Radiopharmaceuticals, also known as radioactive medications, are substances used for the diagnosis or treatment of diseases, including cancer, and contain a radioactive material. These medications are employed in various medical procedures to identify specific illnesses or detect medical issues. Patients may receive radiopharmaceuticals through different administration methods, such as injection, oral ingestion, or application into the eye or bladder.

Radiopharmaceuticals can be broadly categorized into diagnostic, therapeutic, and other types. The process of delivering radioactive atoms to targets associated with tumors is known as radiopharmaceutical therapy. These medications find applications in fields such as oncology, cardiology, gastroenterology, neuroendocrinology, neurology, nephrology, and others. Hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutes, and similar healthcare facilities commonly utilize radiopharmaceuticals for various medical purposes.

The radiopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides radiopharmaceuticals market statistics, including radiopharmaceuticals industry global market size, regional shares, competitors with a radiopharmaceuticals market share, detailed radiopharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the radiopharmaceuticals industry. This radiopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to $6.77 billion in 2024 at a compound annual growth rate (CAGR) of 4.7%. The expansion observed in the historical period can be linked to an increase in healthcare spending, government initiatives, the convenience of treatment, and shifts in lifestyle.

The radiopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $10.59 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. Anticipated growth in the forecast period is attributed to factors such as the increasing geriatric population, a rise in the prevalence of cancer and cardiovascular diseases, substantial capital investments, and the introduction of new products. Notable trends in this period include collaborative efforts with other companies to enhance revenues and product quality, investments in expanding plant capacity to meet growing demand, embracing new technologies to address emerging requirements, incorporating 3D printing technology in manufacturing for cost savings, investment in innovations such as theranostics, striving for category leadership, exploring in silico modeling for a more rational and scientific approach, leveraging AI to reduce research and development costs and expedite drug development, and investing in technologies focused on cardiology to boost revenues. Additionally, adopting disease-specific approaches for accurate and timely diagnosis of cancer is a noteworthy trend.

The escalating prevalence of cancer and cardiovascular diseases is expected to be a driving force for the radiopharmaceuticals market. Radiopharmaceuticals are increasingly recognized as a safe and effective therapeutic alternative to conventional medicines. They offer radiologists a distinct advantage in treating cancer and cardiovascular diseases, primarily due to their targeted therapy benefits. Cancer ranks as the second leading cause of death, with approximately 1 in 6 global deaths attributed to cancer. According to the International Agency for Research on Cancer (IARC), by 2040, the global burden is projected to reach 27.5 million active cancer incidents and 16.3 million cancer deaths, driven by population growth and aging. Notably, around 70% of cancer deaths occur in low- and middle-income countries. As a result, the increasing prevalence of cancer and cardiovascular diseases is expected to fuel the demand for radiopharmaceuticals in treating these conditions.

The radiopharmaceuticals market is anticipated to experience significant growth, driven by the increasing demand for personalized medicine. Personalized medicine, also known as precision medicine, is an innovative approach to medical care that tailors medical decisions, treatments, interventions, and drug therapies to the unique characteristics of each patient. Integrating personalized medicine into radiopharmaceuticals enhances the precision and accuracy of imaging and therapy, enabling healthcare providers to deliver more targeted and effective care. For example, in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34%, or 12 of them, classified as personalized medicines by the Personalized Medicine Coalition (PMC). The increasing demand for personalized medicine is thus a driving force behind the growth of the radiopharmaceuticals market.

Several companies in the radiopharmaceuticals market are adopting strategic initiatives such as opening new manufacturing facilities and expanding plant capacity, gaining significant popularity. ITM Isotopen Technologien Munchen AG (ITM), for instance, launched a new manufacturing facility in the Munich area to increase the production capacity of high-purity (n.c.a.) Lutetium-177 and no-carrier-added (n.c.a.) Lutetium-177-containing radiopharmaceuticals. This move aims to meet the high demand for quality medical isotopes for precision oncology worldwide.

Major players in the radiopharmaceuticals market are forming partnerships to enhance their market profitability. In June 2023, the University of Pittsburgh Medical Center partnered with PharmaLogic Holdings Corporation to produce new radiopharmaceuticals at a Pittsburgh facility. This collaboration enables patients and professionals in the UPMC vicinity to access innovative diagnostic and therapeutic drugs that are not currently available. The non-exclusive agreement outlines the conversion of experimental radiopharmaceuticals into therapeutically useful medications.

In June 2021, Curium, a France-based nuclear medicine solutions provider, acquired IASON for an undisclosed amount. This acquisition is expected to bolster Curium's presence in Europe for its extensive range of life-saving diagnostic techniques. By expanding its geographic reach, Curium aims to serve clients and patients throughout Austria and Central Europe with its diverse range of medications and future pipeline of novel agents. IASON, based in Austria, specializes in radiopharmaceutical development, manufacturing, and distribution for use in positron-emission tomography (PET).

Major companies operating in the radiopharmaceuticals market report are Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE), IBA Group, Bayer AG, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Eckert & Ziegler, Nihon Medi-Physics Co. Ltd., Fujifilm Corporation, ANSTO, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Bracco Imaging SpA., Canon Inc., China Isotope & Radiation Corporation (CIRC), Alliance Medical, Advanced Accelerator Applications, JSC Isotope, Pharm-Sintez, Synektik SA, Polatom, RadioMedic sro, UJV Rez, Actinium Pharmaceuticals Inc., Alseres Pharmaceuticals Inc., Avid Radiopharmaceuticals, Fusion Pharmaceuticals, Peregrine Pharmaceuticals Inc., PETNET Solutions Inc., Positron Corporation, Triad Isotopes Inc., Telix Pharmaceuticals, Rosatom, Alliance Medical Group, Hologic Inc., Segami Corporation, Eczacybaþy-Monrol Nuclear Products, NTP Radioisotopes.

North America was the largest region in the global radiopharmaceuticals market in 2023. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the radiopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the radiopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The radiopharmaceuticals market consists of sales of technetium disofenin, technetium lidofenin, and technetium mebrofenin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiopharmaceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiopharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiopharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Diagnostic; Therapeutic
  • 2) By Application: Oncology; Cardiology; Gastroenterology; Neuroendocrinology; Musculoskeletal; Respiratory; Nephrology; Other Applications
  • 3) By End User: Hospitals And Ambulatory Surgical Centers; Diagnostic Centers; Cancer Research Institutes
  • Companies Mentioned: Cardinal Health; Curium Pharma; Siemens Healthineers AG; Novartis AG; General Electric Company (GE)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiopharmaceuticals Market Characteristics

3. Radiopharmaceuticals Market Trends And Strategies

4. Radiopharmaceuticals Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Radiopharmaceuticals Market Size and Growth

  • 5.1. Global Radiopharmaceuticals Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Radiopharmaceuticals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Radiopharmaceuticals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Radiopharmaceuticals Market Segmentation

  • 6.1. Global Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostic
  • Therapeutic
  • Other Types
  • 6.2. Global Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Cardiology
  • Gastroenterology
  • Neuroendocrinnology
  • Neurology
  • Nephrology
  • Other Applications
  • 6.3. Global Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Cancer Research Institutes
  • Other End Users

7. Radiopharmaceuticals Market Regional And Country Analysis

  • 7.1. Global Radiopharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Radiopharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Radiopharmaceuticals Market

  • 8.1. Asia-Pacific Radiopharmaceuticals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Radiopharmaceuticals Market

  • 9.1. China Radiopharmaceuticals Market Overview
  • 9.2. China Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Radiopharmaceuticals Market

  • 10.1. India Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Radiopharmaceuticals Market

  • 11.1. Japan Radiopharmaceuticals Market Overview
  • 11.2. Japan Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Radiopharmaceuticals Market

  • 12.1. Australia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Radiopharmaceuticals Market

  • 13.1. Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Radiopharmaceuticals Market

  • 14.1. South Korea Radiopharmaceuticals Market Overview
  • 14.2. South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Radiopharmaceuticals Market

  • 15.1. Western Europe Radiopharmaceuticals Market Overview
  • 15.2. Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Radiopharmaceuticals Market

  • 16.1. UK Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Radiopharmaceuticals Market

  • 17.1. Germany Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Radiopharmaceuticals Market

  • 18.1. France Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Radiopharmaceuticals Market

  • 19.1. Italy Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Radiopharmaceuticals Market

  • 20.1. Spain Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Radiopharmaceuticals Market

  • 21.1. Eastern Europe Radiopharmaceuticals Market Overview
  • 21.2. Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Radiopharmaceuticals Market

  • 22.1. Russia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Radiopharmaceuticals Market

  • 23.1. North America Radiopharmaceuticals Market Overview
  • 23.2. North America Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Radiopharmaceuticals Market

  • 24.1. USA Radiopharmaceuticals Market Overview
  • 24.2. USA Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Radiopharmaceuticals Market

  • 25.1. Canada Radiopharmaceuticals Market Overview
  • 25.2. Canada Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Radiopharmaceuticals Market

  • 26.1. South America Radiopharmaceuticals Market Overview
  • 26.2. South America Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Radiopharmaceuticals Market

  • 27.1. Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Radiopharmaceuticals Market

  • 28.1. Middle East Radiopharmaceuticals Market Overview
  • 28.2. Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Radiopharmaceuticals Market

  • 29.1. Africa Radiopharmaceuticals Market Overview
  • 29.2. Africa Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Radiopharmaceuticals Market Competitive Landscape And Company Profiles

  • 30.1. Radiopharmaceuticals Market Competitive Landscape
  • 30.2. Radiopharmaceuticals Market Company Profiles
    • 30.2.1. Cardinal Health
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Curium Pharma
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. General Electric Company (GE)
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Radiopharmaceuticals Market Other Major And Innovative Companies

  • 31.1. IBA Group
  • 31.2. Bayer AG
  • 31.3. Lantheus Medical Imaging Inc.
  • 31.4. Bracco Imaging S.p.A.
  • 31.5. Eckert & Ziegler
  • 31.6. Nihon Medi-Physics Co. Ltd.
  • 31.7. Fujifilm Corporation
  • 31.8. ANSTO
  • 31.9. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
  • 31.10. Bracco Imaging SpA.
  • 31.11. Canon Inc.
  • 31.12. China Isotope & Radiation Corporation (CIRC)
  • 31.13. Alliance Medical
  • 31.14. Advanced Accelerator Applications
  • 31.15. JSC Isotope

32. Global Radiopharmaceuticals Market Competitive Benchmarking

33. Global Radiopharmaceuticals Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Radiopharmaceuticals Market

35. Radiopharmaceuticals Market Future Outlook and Potential Analysis

  • 35.1 Radiopharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Radiopharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Radiopharmaceuticals Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer